InvestSMART

Paragon Care Limited (ASX:PGC)

ALERT: Price-sensitive ASX Announcement for PGC
Current share price for PGC : $0.145 -0.06 (-29.27%)+
Announcement
Release
25 Feb 2026 9:00AM
Price at Release
$0.205
Full Release
download
Summary
Paragon Care Limited's Half Year Report for the period ending 31 December 2025 reveals a challenging financial performance. The company reported a net loss of $21.27 million compared to a net profit of $13.23 million in the previous year, largely due to a significant provision for expected credit losses associated with the Infinity Retail Pharmacy Group. Revenue increased by 3% to $1.9 billion, supported by acquisitions and regional growth strategies. Underlying EBITDA rose by 3.1%, indicating stable operational performance despite the financial setbacks. The report highlights the company's strategic acquisitions, including the Somnotec Group and upcoming acquisitions that are expected to contribute positively in the latter half of FY26. The report also addresses ongoing engagement with Infinity Group's administrators, as Paragon Care remains a significant creditor. The Directors express optimism for a satisfactory resolution regarding receivables from Infinity, though timing and recovery amounts remain uncertain.
Key Points
  • Net loss of $21.27 million reported for half-year ending 31 December 2025.
  • Revenue increased by 3% to $1.9 billion.
  • Underlying EBITDA increased by 3.1% to $49.03 million.
  • Significant provision for expected credit losses related to Infinity Retail Pharmacy Group.
  • Strategic acquisitions include Somnotec Group, with more expected in H2FY26.
  • Continuing engagement with administrators of Infinity Group as a major creditor.
  • Directors express cautious optimism about recovery from Infinity Group.
  • No dividends were paid, recommended, or declared during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.